BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15671017)

  • 1. Binding of HTm4 to cyclin-dependent kinase (Cdk)-associated phosphatase (KAP).Cdk2.cyclin A complex enhances the phosphatase activity of KAP, dissociates cyclin A, and facilitates KAP dephosphorylation of Cdk2.
    Chinami M; Yano Y; Yang X; Salahuddin S; Moriyama K; Shiroishi M; Turner H; Shirakawa T; Adra CN
    J Biol Chem; 2005 Apr; 280(17):17235-42. PubMed ID: 15671017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin.
    Poon RY; Hunter T
    Science; 1995 Oct; 270(5233):90-3. PubMed ID: 7569954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2.
    Song H; Hanlon N; Brown NR; Noble ME; Johnson LN; Barford D
    Mol Cell; 2001 Mar; 7(3):615-26. PubMed ID: 11463386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abolishment of the interaction between cyclin-dependent kinase 2 and Cdk-associated protein phosphatase by a truncated KAP mutant.
    Yeh CT; Lu SC; Chao CH; Chao ML
    Biochem Biophys Res Commun; 2003 May; 305(2):311-4. PubMed ID: 12745075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KAP: a dual specificity phosphatase that interacts with cyclin-dependent kinases.
    Hannon GJ; Casso D; Beach D
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1731-5. PubMed ID: 8127873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Getting in the ring: proline-directed substrate specificity in the cell cycle proteins Cdc14 and CDK2-cyclinA3.
    Gray CH; Barford D
    Cell Cycle; 2003; 2(6):500-2. PubMed ID: 14504459
    [No Abstract]   [Full Text] [Related]  

  • 7. Human HTm4 is a hematopoietic cell cycle regulator.
    Donato JL; Ko J; Kutok JL; Cheng T; Shirakawa T; Mao XQ; Beach D; Scadden DT; Sayegh MH; Adra CN
    J Clin Invest; 2002 Jan; 109(1):51-8. PubMed ID: 11781350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and crystallization of the CDK-associated protein phosphatase KAP expressed in Escherichia coli.
    Hanlon N; Barford D
    Protein Sci; 1998 Feb; 7(2):508-11. PubMed ID: 9521129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity.
    Brown NR; Noble ME; Lawrie AM; Morris MC; Tunnah P; Divita G; Johnson LN; Endicott JA
    J Biol Chem; 1999 Mar; 274(13):8746-56. PubMed ID: 10085115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division.
    Lacy ER; Wang Y; Post J; Nourse A; Webb W; Mapelli M; Musacchio A; Siuzdak G; Kriwacki RW
    J Mol Biol; 2005 Jun; 349(4):764-73. PubMed ID: 15890360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitination of p27Kip1 requires physical interaction with cyclin E and probable phosphate recognition by SKP2.
    Ungermannova D; Gao Y; Liu X
    J Biol Chem; 2005 Aug; 280(34):30301-9. PubMed ID: 15980415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of phosphorylated cyclin-dependent kinase 2 and functional characterization of threonine-160-specific phosphatase KAP.
    Poon RY
    Methods Enzymol; 1997; 283():283-92. PubMed ID: 9251027
    [No Abstract]   [Full Text] [Related]  

  • 13. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
    Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
    Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics.
    Otyepka M; Bártová I; Kríz Z; Koca J
    J Biol Chem; 2006 Mar; 281(11):7271-81. PubMed ID: 16407256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15.
    Gu Y; Rosenblatt J; Morgan DO
    EMBO J; 1992 Nov; 11(11):3995-4005. PubMed ID: 1396589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant transcripts of the cyclin-dependent kinase-associated protein phosphatase in hepatocellular carcinoma.
    Yeh CT; Lu SC; Chen TC; Peng CY; Liaw YF
    Cancer Res; 2000 Sep; 60(17):4697-700. PubMed ID: 10987270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylations of cyclin-dependent kinase 2 revisited using two-dimensional gel electrophoresis.
    Coulonval K; Bockstaele L; Paternot S; Roger PP
    J Biol Chem; 2003 Dec; 278(52):52052-60. PubMed ID: 14551212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of phosphorylated Thr160 for the activation of the CDK2/Cyclin A complex.
    De Vivo M; Cavalli A; Bottegoni G; Carloni P; Recanatini M
    Proteins; 2006 Jan; 62(1):89-98. PubMed ID: 16292742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
    Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
    Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A.
    Kim DM; Yang K; Yang BS
    Exp Mol Med; 2003 Oct; 35(5):421-30. PubMed ID: 14646596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.